Zevra Therapeutics (ZVRA) P/E (2015 - 2026)
Zevra Therapeutics (ZVRA) P/E from Jun 30, 2015 to Jul 20, 2026. The TTM Zevra Therapeutics (ZVRA) P/E is 5.46. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Zevra Therapeutics (ZVRA)
| Year | P/E | Change |
|---|---|---|
| 2026 | 5.46 | -8.28% |
| 2025 | 5.96 | -254.40% |
| 2024 | -3.86 | -65.49% |
| 2023 | -11.18 | +148.48% |
| 2022 | -4.50 | -83.91% |
| 2021 | -27.97 | +107.77% |
| 2020 | -13.46 | +84.70% |
| 2019 | -7.29 | -10.43% |
| 2018 | -8.14 | -63.34% |
| 2017 | -22.20 | -48.94% |
| 2016 | -43.48 | -53.35% |
| 2015 | -93.21 | N/A |
Comparison Zevra Therapeutics (ZVRA) P/E with competitors
Zevra Therapeutics (ZVRA) P/E is 5.46.